Spyre Therapeutics Up Over 19%, on Pace for Largest Percent Increase Since November 2023 -- Data Talk

Dow Jones
Oct 10

Spyre Therapeutics, Inc (SYRE) is currently at $21.14, up $3.46 or 19.54%

 

--Would be highest close since Feb. 24, 2025, when it closed at $21.26

--On pace for largest percent increase since Nov. 28, 2023, when it rose 20.73%

--Currently up three of the past four days

--Currently up two consecutive days; up 31.93% over this period

--Best two-day stretch since the two days ending June 23, 2023, when it rose 275.94%

--Up 26.1% month-to-date

--Down 9.21% year-to-date; on pace for worst year since 2022, when it fell 90.53%

--Down 92.95% from its all-time closing high of $299.75 on April 8, 2016

--Down 22.35% from 52 weeks ago (Oct. 10, 2024), when it closed at $27.22

--Down 46.6% from its 52-week closing high of $39.58 on Nov. 8, 2024

--Up 79.11% from its 52-week closing low of $11.80 on April 8, 2025

--Traded as high as $21.25; highest intraday level since Feb. 26, 2025, when it hit $21.50

--Up 20.19% at today's intraday high; largest intraday percent increase since March 1, 2024, when it rose as much as 20.23%

 

All data as of 1:33:51 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

October 09, 2025 13:37 ET (17:37 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10